, Singapore
594 views
Photo from press release.

Singapore and Malaysia launch medical device regulatory reliance programme

This aims to streamline registration of several medical devices.

Singaporean and Malaysian authorities have launched the Medical Device Regulatory Reliance Programme, a six-month pilot project to fast-track registration of certain medical devices.

According to a joint statement, the Medical Device Authority (MDA) of Malaysia and the Health Sciences Authority (HSA) of Singapore signed a memorandum of understanding for the programme running from 1 September 2025 to 28 February 2026,

The pilot programme will streamline the registration of Class B, C and D medical devices.

Through this initiative, the parties aim to deliver for faster approvals through reliance on each other’s regulatory assessment and approvals, reduce duplications of reviews, cutting costs and time-to-market, and provice earlier patient access to safe, innovative and high quality medical technologies.

“Both regulators will work closely to test streamlined pathways, refine and establish clear standard operating procedures for the reliance pathway, validate shortened processing timelines and gather stakeholders’ feedback, so that an effective and scalable regulatory reliance programme can be built after the pilot,” the statemen read.

Join Singapore Business Review community
Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.